www.fgks.org   »   [go: up one dir, main page]

Press Enter or click the Search button above to view results.

Recent Drug Updates

  • sofosbuvir/velpatasvir/voxilaprevir (Vosevi) FDA approves pangenotypic combination for chronic HCV that includes a new NS3/4A protease inhibitor
  • neratinib (Nerlynx) FDA approves new tyrosine kinase inhibitor for extended adjuvant treatment of early stage HER2-positive breast cancer
  • guselkumab (Tremfya) FDA approved for moderate-to-severe chronic plaque psoriasis in patients who are candidates for systemic therapy or phototherapy
  • glutamine (Endari) FDA approves for reducing severe complications associated with sickle cell disease
  • abatacept (Orencia) New indication approved for psoriatic arthritis
  • daratumumab (Darzalex) FDA approved daratumumab in combination with pomalidomide and dexamethasone for patients with multiple myeloma